E-book consumers choosing tablets over e-readers, says BISG Study - May 1, 2012
E-book consumers’ preference for tablets is accelerating rapidly as dedicated e-readers drop in popularity, according to the Book Industry Study Group’s (BISG) Consumer Attitudes Toward E-Book Reading survey. The second installment in Volume Three of the study shows that, over the course of just six months,… Read More
GenomeQuest and Questel partner for IP platform integration - May 1, 2012
US-based Questel, a provider of online information services, and GenomeQuest, a provider of large-scale genomic software applications, have announced a partnership to integrate their respective platforms for researching and managing global IP. Specifically, GQ-IP users will now have the option to review biological sequence patents directly… Read More
A-levels not equipping students with appropriate mathematical skills, says SCORE report - April 30, 2012
The UK's Royal Society of Chemistry (RSC) hosted an event at the Chemistry Centre in London last week, at which the science-alliance SCORE launched a report on A levels and science. RSC is a SCORE partner. New evidence shows that A-levels in a range of… Read More
Journal of Infusion Nursing unveils iPad edition at INS conference - April 30, 2012
Journal of Infusion Nursing, the official publication of the Infusion Nurses Society (INS), has unveiled an iPad app. It is being showcased at the INS 2012 Annual Conference in Las Vegas, April 28 - May 3. The Journal of Infusion Nursing is published by Lippincott Williams… Read More
ARL calls for proposals for 2013 SPEC survey topics - April 25, 2012
The Association of Research Libraries (ARL) is seeking proposals for 2013 SPEC survey topics. For 40 years ARL has gathered and disseminated data through the SPEC survey programme to assist libraries in the continuous improvement of their management systems. Proposals for topics for the 2013 SPEC… Read More
Thomson Reuters launches new oncology application for tablet devices for R&D Pharmaceutical leaders - April 25, 2012
The Intellectual Property & Science division of Thomson Reuters has announced its commitment to support R&D pharmaceutical leaders with a new oncology application for mobile tablet devices, already in use by AstraZeneca executives. The rich visualisation dashboard leverages content from Thomson Reuters Cortellis, the company's flagship… Read More
